STAT+: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors
Why this matters: health reporting relevant to everyday decisions and well-being.
Takeda Pharmaceuticals agreed to pay $13.6 million to settle allegations that it paid kickbacks to doctors to prescribe an antidepressant and, consequently, violated federal law by causing Medicaid to pay false claims, the U.S. Department of Justice said in announcing the settlement. From January 2014 to October 2020, the company allegedly offered speaking fees and paid for meals at “high-end” restaurants to persuade physicians to prescribe Trintellix. Moreover, certain doctors who attended multiple programs on the same topic and received meals and drinks did not gain any educational benefit from attending the programs. “This settlement demonstrates the continued commitment of my office to ensure that patients’ best interests remain paramount,” Eric Grant, the U.S. attorney for the Eastern District of California, said in a statement. “Prescribing decisions should not be influenced by drug companies’ payments or side perks made available to physicians.”Continue to STAT+ to read the full story…